You are viewing the site in preview mode

Skip to main content

Peer Review reports

From: FROP-1 peptide-conjugated ultrasmall superparamagnetic nanoparticles as a targeted T1-weighted MR contrast agent for breast cancer: in vitro study

Original Submission
15 Dec 2024 Submitted Original manuscript
25 Dec 2024 Author responded Author comments - Samideh Khoei
17 Feb 2025 Reviewed Reviewer Report
15 Mar 2025 Reviewed Reviewer Report
26 Mar 2025 Author responded Author comments - Samideh Khoei
Resubmission - Version 2
25 Dec 2024 Submitted Manuscript version 2
27 Mar 2025 Author responded Author comments - Samideh Khoei
Resubmission - Version 3
27 Mar 2025 Submitted Manuscript version 3
Publishing
2 Apr 2025 Editorially accepted
1 May 2025 Article published 10.1186/s42490-025-00091-7

You can find further information about peer review here.

Back to article page